Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00790 (
PGA
)
2,475
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The stability-pH profile of the gamma-aminobutyric acid prodrug.
Progabide
, was found to be bell shaped, with maximum stability occurring at pH 6 to 7 with a t1/2 of 126 min. Of its metabolic derivatives, the deamidated product
PGA
degraded in a similar fashion to
Progabide
, whereas the hydrolytic degradation product SL79.182 was, a expected, a stable compound.
Progabide
behaved as a typical weak base, with its solubility increasing with a decrease in pH. SL79.182 behaved as a typical phenolic weak acid, with its solubility increasing with an increase in pH. Both compounds displayed low intrinsic solubilities of 14.5 x 10(-5) M for
Progabide
and 33.4 x 10(-6) M for SL79.182. An increase in temperature resulted in an increase in the solubility but a decrease in the stability of
Progabide
. The data obtained indicate that the gastric pH and gastric emptying rate will have a profound effect on the oral bioavailability of
Progabide
.
...
PMID:The stability and solubility of progabide and its related metabolic derivatives. 324 2